Imunon (IMNN) Intangibles (2010 - 2022)
Imunon's (IMNN) quarterly Intangibles came in at $1.6 million in Q4 2022, down 88.03% YoY from $13.4 million in Q4 2021, and down 88.06% on a QoQ basis from $13.4 million in Q3 2022.
Imunon (IMNN) Intangibles (2010 - 2022) Analysis & Trends
Imunon (IMNN) has 13 years of Intangibles data on file, last reported at $1.6 million in Q4 2022.
- Quarterly Intangibles fell 88.03% year-over-year to $1.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.6 million (down 88.03% YoY) and the FY2022 annual result came in at $1.6 million, down 88.03% from the prior year.
- Intangibles retreated to $1.6 million in Q4 2022, from $13.4 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $15.7 million in Q1 2019 to a low of $284147.0 in Q1 2020.
- A 5-year average of $7.6 million and a median of $7.6 million in 2019 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2020 — Intangibles plunged 98.19% — and 2021, when it jumped 4580.68%.
- Tracing IMNN's Intangibles over 5 years: stood at $568292.0 in 2018, then soared by 247.73% to $2.0 million in 2019, then changed by 0.0% to $2.0 million in 2020, then surged by 576.39% to $13.4 million in 2021, then tumbled by 88.03% to $1.6 million in 2022.
- The last three Intangibles figures came in at $1.6 million (Q4 2022), $13.4 million (Q3 2022), and $13.4 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 93.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 13.40 Mn |
| Jun 30, 2022 | 13.37 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 13.37 Mn |
| Sep 30, 2021 | 13.30 Mn |
| Jun 30, 2021 | 13.37 Mn |
| Mar 31, 2021 | 13.30 Mn |
| Dec 31, 2020 | 1.98 Mn |
| Sep 30, 2020 | 13.37 Mn |
| Jun 30, 2020 | 15.74 Mn |
| Mar 31, 2020 | 284,147.00 |
| Dec 31, 2019 | 1.98 Mn |
| Sep 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 15.74 Mn |
| Mar 31, 2019 | 15.74 Mn |
| Dec 31, 2018 | 568,292.00 |
| Sep 30, 2018 | 625,121.00 |
| Jun 30, 2018 | 681,950.00 |
| Mar 31, 2018 | 738,779.00 |